Position in IDYA
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$11,603,380
+$11,019,147 QoQ
Shares Held
311,333
+1742.2% QoQ
Ownership
0.323%
of shares outstanding
% of Portfolio
0.40%
of 13F equity value
Holder Rank
#44
of 282 holders
Holding Since
Mar 2023
9 quarters on record
Voting authority
Sole 36%
Shared 0%
None 64%
Common Shares in IDYA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BIT Capital GmbH holds $38,342,132 across 19 Biotechnology names. IDYA ranks #1 (30.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IDYA |
IDEAYA Biosciences, Inc.
This page
|
311,333 | $11,603,380 | |
| 2 | DFTX |
Definium Therapeutics, Inc.
|
128,131 | $6,027,282 | |
| 3 | RARE |
Ultragenyx Pharmaceutical Inc.
|
91,391 | $3,051,545 | |
| 4 | RCUS |
Arcus Biosciences, Inc.
|
60,000 | $1,849,800 | |
| 5 | IMNM |
Immunome Inc.
|
83,400 | $1,767,246 | |
| 6 | ATAI |
AtaiBeckley Inc.
|
320,576 | $1,689,435 | |
| 7 | NKTR |
Nektar Therapeutics
|
21,100 | $1,472,991 | |
| 8 | IONS |
Ionis Pharmaceuticals Inc
|
16,300 | $1,292,427 |
All Filings in IDYA
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,603,380 | 311,333 | Shares | Sole | 2026-08-12 | |
| 2025-12-31 | $584,233 | 16,900 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $82,146 | 3,019 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $88,704 | 4,220 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $699,671 | 42,715 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $1,636,370 | 63,672 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $1,090,203 | 34,413 | Shares | Sole | 2025-02-12 | |
| 2023-12-31 | $150,752 | 4,237 | Shares | Sole | 2025-02-12 | |
| 2023-03-31 | $466,874 | 34,004 | Shares | Sole | 2025-02-12 | |
| No filing history on record for this holder in this stock. | ||||||